| Scopolamine, a toxin-induced experimental model, used for research in Alzheimer’s disease WN Chen, KY Yeong CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2020 | 67 | 2020 |
| The gut-brain-axis on the manifestation of depressive symptoms in epilepsy: an evidence-driven hypothesis MF Shaikh, CY Lee, WN Chen, FA Shaikh Frontiers in pharmacology 11, 465, 2020 | 15 | 2020 |
| Sirtuin inhibition and anti-cancer activities of ethyl 2-benzimidazole-5-carboxylate derivatives KY Yeong, MIHN Azizi, N Berdigaliyev, WN Chen, WL Lee, AN Shirazi, ... Medchemcomm 10 (12), 2140-2145, 2019 | 15 | 2019 |
| Poloxamer 188 (P188), A potential polymeric protective agent for central nervous system disorders: a systematic review WN Chen, MF Shaikh, S Bhuvanendran, A Date, MT Ansari, ... Current neuropharmacology 20 (4), 799, 2022 | 11 | 2022 |
| Neuroprotective, neurite enhancing, and cholinesterase inhibitory effects of Lamiaceae family essential oils in Alzheimer’s disease model WN Chen, KW Chin, K San Tang, S Agatonovic-Kustrin, KY Yeong Journal of Herbal Medicine 41, 100696, 2023 | 5 | 2023 |
| Potential roles of α-amylase in Alzheimer’s disease: Biomarker and drug target WN Chen, K San Tang, KY Yeong Current neuropharmacology 20 (8), 1554, 2022 | 4 | 2022 |
| Handbook of Animal Models in Neurological Diseases MFS Win Ning Chen | | 2022 |
